Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Core Laboratories (CLB) Accumulated Expenses (2022 - 2026)

Core Laboratories filings provide 5 years of Accumulated Expenses readings, the most recent being $22.3 million for Q1 2026.

  • On a quarterly basis, Accumulated Expenses fell 7.29% to $22.3 million in Q1 2026 year-over-year; TTM through Mar 2026 was $22.3 million, a 7.29% decrease, with the full-year FY2025 number at $26.5 million, up 15.82% from a year prior.
  • Accumulated Expenses hit $22.3 million in Q1 2026 for Core Laboratories, down from $26.5 million in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $26.5 million in Q4 2025 to a low of $18.8 million in Q4 2023.
  • Median Accumulated Expenses over the past 5 years was $22.3 million (2026), compared with a mean of $22.4 million.
  • Biggest five-year swings in Accumulated Expenses: fell 19.8% in 2023 and later grew 21.87% in 2024.
  • Core Laboratories' Accumulated Expenses stood at $23.4 million in 2022, then fell by 19.8% to $18.8 million in 2023, then increased by 21.87% to $22.9 million in 2024, then grew by 15.82% to $26.5 million in 2025, then dropped by 15.95% to $22.3 million in 2026.
  • The last three reported values for Accumulated Expenses were $22.3 million (Q1 2026), $26.5 million (Q4 2025), and $23.4 million (Q3 2025) per Business Quant data.